Fumikata Hara

1.4k citations
82 papers · 883 indexed · h-index 17
Topics
HER2/EGFR in Cancer Research (34 papers)Cancer Treatment and Pharmacology (32 papers)Breast Cancer Treatment Studies (31 papers)

In The Last Decade

Fumikata Hara

80 papers receiving 871 citations

Peers

Fumikata Hara
Comparison fields: 5 of 87
  • Oncology 501
  • Cancer Research 298
  • Pulmonary and Respiratory Medicine 277
  • Molecular Biology 182
  • Radiology, Nuclear Medicine and Imaging 130
Replace Antonio Febbraro with:
Antonio Febbraro Italy
Rubina Qamar United States
Jean-Luc Canon Belgium
Koung Jin Suh South Korea
Daisuke Takabatake Japan
Eleni Timotheadou Greece
Muneaki Sano Japan
K. Gunnarsdóttir Denmark
Tracey Weisberg United States
Erin Macrae United States
Fumikata Hara relative to Antonio Febbraro Italy Antonio Febbraro's profile →
Citations per field
00.5×1.5×2.0×
Antonio Febbraro · 1×
Citations per year

Countries citing papers authored by Fumikata Hara

Since Specialization
Citations

This map shows the geographic impact of Fumikata Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumikata Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumikata Hara more than expected).

Fields of papers citing papers by Fumikata Hara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumikata Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumikata Hara. The network helps show where Fumikata Hara may publish in the future.

Co-authorship network of co-authors of Fumikata Hara

This figure shows the co-authorship network connecting the top 25 collaborators of Fumikata Hara. A scholar is included among the top collaborators of Fumikata Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumikata Hara. Fumikata Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 4
5 2
6 1
7 1
8 1
9 12
10 8
11 3
12 41
13 68
14 9
15 21
16 12
17 1
18 15
19 9
20 22

About Fumikata Hara

Fumikata Hara is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 82 papers that have together received 883 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (34 papers), Cancer Treatment and Pharmacology (32 papers) and Breast Cancer Treatment Studies (31 papers). The work is most often cited by research in Cancer Research (298 citations), Oncology (501 citations) and Pulmonary and Respiratory Medicine (277 citations). Fumikata Hara has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Naruto Taira, Shozo Ohsumi, Daisuke Takabatake, Hirofumi Mukai, Tadahiko Shien, Hiroyoshi Doihara, Kenjiro Aogi, Seiki Takashima, Nobuyoshi Shimizu and Tatsuya Toyama. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026